Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2021	May 07, 2021
Details
Registrant CIK	0001104280
Fiscal Year End	--06-30
Registrant Name	SANGUI BIOTECH INTERNATIONAL INC
SEC Form	10-Q/A
Period End date	Mar. 31, 2021
Tax Identification Number (TIN)	84-1330732
Number of common stock shares outstanding		206,901,842
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Shell Company	false
Small Business	true
Emerging Growth Company	false
Amendment Description	The purpose of this Amendment No. 1 to the Periodic Report of Sangui Biotech International, Inc. (the “Company”) on Form 10-Q for the fiscal period ended March 31, 2021, filed with the Securities and Exchange Commission on May 7, 2021 (the “Form 10-Q”) is to correct the information in Part II Item 2. The Company in its Form 10-Q filing indicated that there had been no unregistered sales of its equity securities, while in fact there had been a sale of stock subsequent to the period covered by the report. This Amendment No. 1 corrects this section to reflect the recent issuance. No changes are hereby made to the registrant’s financial statements.
Document Quarterly Report	true
Entity File Number	0-21271
Entity Address, State or Province	CO
Entity Incorporation, State or Country Code	CO
Entity Address, Address Line One	Bleichenbrücke 9
Entity Address, Postal Zip Code	20354
Entity Address, City or Town	Hamburg
Entity Address, Country	DE
Country Region	49
City Area Code	40
Local Phone Number	46093120
Document Transition Report	false
Amendment Flag	true
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3